Proteolysis of human bone collagen by cathepsin K: Characterization of the cleavage sites generating the cross-linked N-telopeptide neoepitope

Bone

Volumn 26, Issue 3, 2000, Pages 241-247

  Atley, L M ^a   Mort, J S ^b   Lalumiere, M ^c   Eyre, D R ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Biochemical markers; Bone resorption; Cathepsin K; Neoepitope; NTx; Type I collagen

Indexed keywords

CATHEPSIN B; CATHEPSIN K; CATHEPSIN L; CATHEPSIN S; COLLAGEN; COLLAGENASE; COLLAGENASE 3; EPITOPE; MATRILYSIN; RECOMBINANT ENZYME; STROMELYSIN;

ADULT; ARTICLE; BONE MATRIX; CASE REPORT; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; OSTEOLYSIS; PEPTIDE MAPPING; PROTEIN ANALYSIS; PROTEIN DEGRADATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0033969472     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(99)00270-7     Document Type: Article

References (47)

1. Aibe K., Yazawa H., Abe K., Teramura K., Kumegawa M., Kawashima H., Honda K. Substrate specificity of recombinant osteoclast-specific cathepsin K from rabbits. Biol Pharm Bull. 19:1996;1026-1031.
2. Apone S., Lee M.Y., Eyre D.R. Osteoclasts generate cross-linked collagen N-telopeptides (NTx) but not free pyridinolines when culture on human bone. Bone. 21:1997;129-136.
3. Bromme D., Okamoto K., Wang B.B., Biroc S. Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme. J Biol Chem. 271:1996;2126-2132.
4. Calvo M., Eyre D.R., Gundberg C.M. Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev. 17:1996;333-368.
5. Chesnut C.H. 3rd, Bell N.H., Clark G.S., Drinkwater B.L., English S.C., Johnson C.C. Jr, Notelovitz M., Rosen C., Cain D.F., Flessland K.A., Mallinak N.J. Hormone replacement therapy in postmenopausal women urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density . Am J Med. 102:1997;29-37.
6. Clemens J.D., Herrick M.V., Singer F.R., Eyre D.R. Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption. Clin Chem. 43:1997;2058-2063.
7. Coulombe R., Li Y., Takebe S., Menard R., Mason P., Mort J.S., Cygler M. Crystallization and preliminary X-ray diffraction studies of human procathepsin L. Proteins. 25:1996;398-400.
8. Del Nery E., Juliano M.A., Meldal M., Svendsen I., Scharfstein J., Walmsley A., Juliano L. Characterization of the substrate specificity of the major cysteine protease (cruzipain) from Trypanosoma cruzi using a portion-mixing combinatorial library and fluorogenic peptides. Biochem J. 323:1997;427-433.
9. Delaisse J.M., Eeckhout Y., Neff L., Francois-Gillet C., Henriet P., Su Y., Vaes G., Baron R. (Pro)collagenase (matrix metalloproteinase-1) is present in rodent osteoclasts and in the underlying bone-resorbing compartment. J Cell Sci. 106:1993;1071-1082.
10. Delaisse J.M., Eeckhout Y., Vaes G. Bone-resorbing agents affect the production and distribution of procollagenase as well as the activity of collagenase in bone tissue. Endocrinology. 123:1988;264-276.
11. Delaisse J.M., Eeckhout Y., Vaes G. In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption. Biochem Biophys Res Commun. 125:1984;441-447.
12. Delaisse J.M., Ledent P., Vaes G. Collagenolytic cysteine proteinases of bone tissue. Cathepsin B, (pro)cathepsin L and a cathepsin L-like 70 kDa proteinase. Biochem J. 279:1991;167-174.
13. Drake F.H., Dodds R.A., James I.E., Connor J.R., Debouck C., Richardson S., Lee-Rykaczewski E., Coleman L., Rieman D., Barthlow R., Hastings G., Gowen M. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem. 271:1996;12511-12516.
14. Ebeling P.R., Atley L.M., Guthrie J.R., Burger H.G., Dennerstein L., Hopper J.L., Wark J.D. Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab. 81:1996;3366-3371.
15. Everts V., Delaisse J.M., Korper W., Beertsen W. Cysteine proteinases and matrix metalloproteinases play distinct roles in the subosteoclastic resorption zone. J Bone Miner Res. 13:1998;1420-1430.
16. Everts V., Delaisse J.M., Korper W., Niehof A., Vaes G., Beertsen W. Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases. J Cell Physiol. 150:1992;221-231.
17. Garnero P., Borel O., Byrjalsen I., Ferreras M., Drake F.H., McQueney M.S., Foged N.T., Delmas P.D., Delaisse J.M. The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem. 273:1998;32347-32352.
18. Garnero P., Shih W.J., Gineyts E., Karpf D.B., Delmas P.D. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab. 79:1994;1693-1700.
19. Gelb B.D., Shi G.P., Chapman H.A., Desnick R.J. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science. 273:1996;1236-1238.
20. Gertz B.J., Clemens J.D., Holland S.D., Yuan W., Greenspan S. Application of a new serum assay for type I collagen cross-linked N- telopeptides assessment of diurnal changes in bone turnover with and without alendronate treatment . Calcif Tissue Int. 63:1998;102-106.
21. Gertz B.J., Shao P., Hanson D.A., Quan H., Harris S.T., Genant H.K., Chesnut C.H. 3rd, Eyre D.R. Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine. J Bone Miner Res. 9:1994;135-142.
22. Hanson D., Weis M.A., Bollen A.-M., Maslan S.L., Singer F.R., Eyre D.R. A specific immunoassay for monitoring human bone resorption quantitation of type I collagen cross-linked N-telopeptides in urine . J Bone Miner Res. 7:1992;1251-1258.
23. Hanson D.A., Eyre D.R. Molecular site specificity of pyridinoline and pyrrole cross-links in type I collagen of human bone. J Biol Chem. 271:1996;26508-26516.
24. Hill P.A., Murphy G., Docherty A.J., Hembry R.M., Millican T.A., Reynolds J.J., Meikle M.C. The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J Cell Sci. 107:1994;3055-3064.
25. Illy C., Quraishi O., Wang J., Purisima E., Vernet T., Mort J.S. Role of the occluding loop in cathepsin B activity. J Biol Chem. 272:1997;1197-1202.
26. Inui T., Ishibashi O., Inaoka T., Origane Y., Kumegawa M., Kokubo T., Yamamura T. Cathepsin K antisense oligodeoxynucleotide inhibits osteoclastic bone resorption. J Biol Chem. 272:1997;8109-8112.
27. Kafienah W., Bromme D., Buttle D.J., Croucher L.J., Hollander A.P. Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J. 331:1998;727-732.
28. Kamiya T., Kobayashi Y., Kanaoka K., Nakashima T., Kato Y., Mizuno A., Sakai H. Fluorescence microscopic demonstration of cathepsin K activity as the major lysosomal cysteine proteinase in osteoclasts. J Biochem (Tokyo). 123:1998;752-759.
29. Littlewood-Evans A., Kokubo T., Ishibashi O., Inaoka T., Wlodarski B., Gallagher J.A., Bilbe G. Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry. Bone. 20:1997;81-86.
30. Nagler D.K., Tam W., Storer A.C., Krupa J.C., Mort J.S., Menard R. Interdependency of sequence and positional specificities for cysteine proteases of the papain family. Biochemistry. 38:1999;4868-4874.
31. Okada Y., Naka K., Kawamura K., Matsumoto T., Nakanishi I., Fujimoto N., Sato H., Seiki M. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts implications for bone resorption . Lab Invest. 72:1995;311-322.
32. Peeters-Joris C., Hammani K., Singer C.F. Differential regulation of MMP-13 (collagenase-3) and MMP-3 (stromelysin-1) in mouse calvariae. Biochim Biophys Acta. 1405:1998;14-28.
33. Prestwood K.M., Pilbeam C.C., Burleson J.A., Woodiel F.N., Delmas P.D., Deftos L.J., Raisz L.G. The short-term effects of conjugated estrogen on bone turnover in older women. J Clin Endocrinol Metab. 79:1994;366-371.
34. Rantakokko J., Aro H.T., Savontaus M., Vuorio E. Mouse cathepsin K cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development . FEBS Lett. 393:1996;307-313.
35. Rosen H.N., Dresner-Pollak R., Moses A.C., Rosenblatt M., Zeind A.J., Clemens J.D., Greenspan S.L. Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover. Calcif Tissue Int. 54:1994;26-29.
36. Rosen H.N., Moses A.C., Garber J., Ross D.S., Lee S.L., Greenspan S.L. Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates. Calcif Tissue Int. 63:1998;363-368.
37. Saftig P., Hunziker E., Wehmeyer O., Jones S., Boyde A., Rommerskirch W., Moritz J.D., Schu P., von Figura K. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci USA. 95:1998;13453-13458.
38. Sato T., del Carmen Ovejero M., Hou P., Heegaard A.M., Kumegawa M., Foged N.T., Delaisse J.M. Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts. J Cell Sci. 110:1997;589-596.
39. Scariano J.K., Glew R.H., Bou-Serhal C.E., Clemens J.D., Garry P.J., Baumgartner R.N. Serum levels of cross-linked N-telopeptides and aminoterminal propeptides of type I collagen indicate low bone mineral density in elderly women. Bone. 23:1998;471-477.
40. Schechter I., Berger A. On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun. 27:1967;157-162.
41. Sone T., Miyake M., Takeda N., Fukunaga M. Urinary excretion of type I collagen crosslinked N-telopeptides in healthy Japanese adults age- and sex-related changes and reference limits . Bone. 17:1995;335-339.
42. Taga M., Uemura T., Minaguchi H. The effect of hormone replacement therapy in postmenopausal women on urinary C-telopeptide and N-telopeptide of type I collagen, new markers of bone resorption. J Endocrinol Invest. 21:1998;154-159.
43. Tezuka K., Nemoto K., Tezuka Y., Sato T., Ikeda Y., Kobori M., Kawashima H., Eguchi H., Hakeda Y., Kumegawa M. Identification of matrix metalloproteinase 9 in rabbit osteoclasts. J Biol Chem. 269:1994;15006-15009.
44. Tezuka K., Tezuka Y., Maejima A., Sato T., Nemoto K., Kamioka H., Hakeda Y., Kumegawa M. Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J Biol Chem. 269:1994;1106-1109.
45. Turk D., Guncar G., Podobnik M., Turk B. Revised definition of substrate binding sites of papain-like cysteine proteases. Biol Chem. 379:1998;137-147.
46. Votta B.J., Levy M.A., Badger A., Bradbeer J., Dodds R.A., James I.E., Thompson S., Bossard M.J., Carr T., Connor J.R., Tomaszek T.A., Szewczuk L., Drake F.H., Veber D.F., Gowen M. Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo. J Bone Miner Res. 12:1997;1396-1406.
47. Wilson, C. and Matrisian, L. M. In: Parks, W. C. and Mecham, R. P., Eds. Matrix Metalloproteinases. San Diego: Academic Press; 1998; 149-184.